Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.26B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.12B |
| 3 |
Apple
AAPL
|
+$986M |
| 4 |
Amazon
AMZN
|
+$676M |
| 5 |
Kenvue
KVUE
|
+$501M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.26B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$638M |
| 3 |
Microsoft
MSFT
|
+$630M |
| 4 |
Meta Platforms (Facebook)
META
|
+$578M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$453M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.81% |
| 2 | Technology | 2.36% |
| 3 | Consumer Discretionary | 1.65% |
| 4 | Financials | 1.08% |
| 5 | Healthcare | 0.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10676
PUT
Achieve Life Sciences
ACHV
$861M
| $125K | ﹤0.01% |
29,000
+4,500
| +18% | +$22.7K |
|
|
SLAI
10677
CALL
DELISTED
SOLAI Ltd ADS
SLAI
| $125K | ﹤0.01% |
6,471
+3,985
| +160% | +$88K |
|
|
ENX
10678
DELISTED
Eaton Vance New York Municipal Bond Fund
ENX
| $124K | ﹤0.01% |
15,003
+650
| +5% | +$5.99K |
|
10679
CALL
Adtran
ADTN
$631M
| $124K | ﹤0.01% |
15,100
+4,700
| +45% | +$41.8K |
|
10680
Beyond Air
XAIR
$4.58M
| $124K | ﹤0.01% |
134
-99
| -42% | -$130K |
|
10681
CALL
Aldeyra Therapeutics
ALDX
$92.3M
| $124K | ﹤0.01% |
18,600
-2,700
| -13% | -$20K |
|
|
YMAB
10682
DELISTED
Y-mAbs Therapeutics
YMAB
| $124K | ﹤0.01% |
22,710
-26,309
| -54% | -$153K |
|
10683
CALL
Anixa Biosciences
ANIX
$124M
| $124K | ﹤0.01% |
37,800
+11,600
| +44% | +$40.6K |
|
|
BNY
10684
DELISTED
BlackRock New York Municipal Income Trust
BNY
| $123K | ﹤0.01% |
13,569
+1,443
| +12% | +$14.3K |
|
|
PAI
10685
Western Asset Investment Grade Income Fund
PAI
$113M
| $123K | ﹤0.01% |
+10,957
| New | +$127K |
|
10686
CALL
Lands' End
LE
$370M
| $123K | ﹤0.01% |
16,500
-49,300
| -75% | -$419K |
|
10687
CALL
Caledonia Mining Corp
CMCL
$487M
| $123K | ﹤0.01% |
12,500
-1,500
| -11% | -$16.6K |
|
10688
Hyperfine
HYPR
$89.4M
| $123K | ﹤0.01% |
+60,089
| New | +$139K |
|
10689
PUT
Adaptive Biotechnologies
ADPT
$4.26B
| $123K | ﹤0.01% |
22,600
-37,500
| -62% | -$248K |
|
|
SBI
10690
Western Asset Intermediate Muni Fund
SBI
$107M
| $123K | ﹤0.01% |
17,190
+2,376
| +16% | +$17.9K |
|
10691
Stereotaxis
STXS
$148M
| $123K | ﹤0.01% |
+77,879
| New | +$125K |
|
10692
CALL
Kartoon Studios
TOON
$39.6M
| $123K | ﹤0.01% |
87,800
-177,400
| -67% | -$315K |
|
|
INFN
10693
CALL
DELISTED
Infinera Corporation Common Stock
INFN
| $123K | ﹤0.01% |
29,400
-67,900
| -70% | -$293K |
|
10694
PUT
Haleon
HLN
$44.2B
| $122K | ﹤0.01% |
14,700
-13,700
| -48% | -$114K |
|
10695
CALL
Fennec Pharmaceuticals
FENC
$412M
| $122K | ﹤0.01% |
16,300
-35,600
| -69% | -$290K |
|
|
BFZ
10696
DELISTED
BlackRock CA Municipal Income Trust
BFZ
| $122K | ﹤0.01% |
11,895
-2,204
| -16% | -$24.9K |
|
10697
TH International
THCH
$40.7M
| $122K | ﹤0.01% |
13,459
-145
| -1% | -$1.75K |
|
|
NOTV
10698
PUT
DELISTED
Inotiv
NOTV
| $122K | ﹤0.01% |
39,500
+11,500
| +41% | +$52.6K |
|
|
DRD
10699
PUT
DRDGold
DRD
$2.6B
| $121K | ﹤0.01% |
14,600
-1,100
| -7% | -$11.1K |
|
10700
The Joint Corp
JYNT
$120M
| $121K | ﹤0.01% |
13,461
-5,776
| -30% | -$65.3K |
|
Similar funds
Jeff Yass's Q3 2023 Portfolio in Review
As of Q3 2023, Jeff Yass held 13,532 positions worth $481B, down 2.3% from $492B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q3 2023 filing shows 1,585 new, 5,250 increased, 4,926 reduced and 1,614 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 632,356 shares worth $52.2M. The largest sale was NVIDIA, an estimated $1.26B.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, up from 90% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2023 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 632,356 shares worth $52.2M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.26B increase.
- Jeff Yass's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $1.26B.
- Jeff Yass fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $45.6M.
- Jeff Yass's ten largest holdings make up 28% of its $481B portfolio in Q3 2023.
- Jeff Yass opened 1,585 new positions and closed 1,614 in Q3 2023.
- Jeff Yass's portfolio value fell 2.3% quarter-over-quarter to $481B.
Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.